Your browser doesn't support javascript.
loading
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Rose, Angela Mc; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrovic, Goranka; Niessen, F Annabel; Machado, Ausenda; Launay, Odile; Denayer, Sarah; Seyler, Lucie; Baruch, Joaquin; Burgui, Cristina; Loghin, Isabela I; Domegan, Lisa; Vaikutyte, Roberta; Husa, Petr; Panagiotakopoulos, George; Aouali, Nassera; Dürrwald, Ralf; Howard, Jennifer; Pozo, Francisco; Sastre-Palou, Bartolomé; Nonkovic, Diana; Knol, Mirjam J; Kislaya, Irina; Luong Nguyen, Liem Binh; Bossuyt, Nathalie; Demuyser, Thomas; Dziugyte, Ausra; Martínez-Baz, Iván; Popescu, Corneliu; Duffy, Róisín; Kuliese, Monika; Soucková, Lenka; Michelaki, Stella; Simon, Marc; Reiche, Janine; Otero-Barrós, María Teresa; Lovric Makaric, Zvjezdana; Bruijning-Verhagen, Patricia Cjl; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; Van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O'Donnell, Joan; Jonikaite, Indre; Demlová, Regina.
Afiliação
  • Rose AM; Epiconcept, Paris, France.
  • Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
  • Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • Petrovic G; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Niessen FA; Croatian Institute of Public Health, Zagreb, Croatia.
  • Machado A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Launay O; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
  • Denayer S; Inserm, CIC Cochin-Pasteur, Paris, France.
  • Seyler L; AP-HP, Hôpital Cochin, Paris, France.
  • Baruch J; Faculty of Medicine, University of Paris City, Paris, France.
  • Burgui C; Sciensano, Brussels, Belgium.
  • Loghin II; Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Domegan L; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta.
  • Vaikutyte R; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
  • Husa P; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Panagiotakopoulos G; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
  • Aouali N; Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
  • Dürrwald R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Howard J; Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Pozo F; Faculty of Medicine, Masaryk University, Brno, Czechia.
  • Sastre-Palou B; University Hospital Brno, Brno, Czechia.
  • Nonkovic D; National Public Health Organisation (EODY), Athens, Greece.
  • Knol MJ; Luxembourg Institute of Health, Luxembourg.
  • Kislaya I; Robert Koch Institute, Berlin, Germany.
  • Luong Nguyen LB; Epiconcept, Paris, France.
  • Bossuyt N; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
  • Demuyser T; Servicio de Medicina Preventiva Hospital Universitario Son Espases, Servicio de Epidemiología, Consellería de Salut, Palma, Spain.
  • Dziugyte A; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
  • Martínez-Baz I; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Popescu C; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
  • Duffy R; AP-HP, Hôpital Cochin, Paris, France.
  • Kuliese M; Sciensano, Brussels, Belgium.
  • Soucková L; Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Michelaki S; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta.
  • Simon M; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
  • Reiche J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Otero-Barrós MT; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
  • Lovric Makaric Z; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Bruijning-Verhagen PC; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Gomez V; Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Lesieur Z; University Hospital Brno, Brno, Czechia.
  • Barbezange C; National Public Health Organisation (EODY), Athens, Greece.
  • Van Nedervelde E; Centre Hospitalier de Luxembourg, Luxembourg.
  • Borg ML; Robert Koch Institute, Berlin, Germany.
  • Castilla J; Servicio de Epidemiología, Dirección General de Salud Pública, Consejería de Sanidad de Galicia, Santiago de Compostela, A Coruna, Spain.
  • Lazar M; Croatian Institute of Public Health, Zagreb, Croatia.
  • O'Donnell J; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Jonikaite I; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Demlová R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Euro Surveill ; 28(47)2023 11.
Article em En | MEDLINE | ID: mdl-37997666

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França